drug prices
Oct 02 | Jay Hancock, Kaiser Health News
The narrative from PhRMA's publicity campaign is only the rosiest, most self-serving version of pricing say critics.
AIDS program investments would yield returns
Sep 29 | Jeff Lagasse
Since almost 75 percent of costs are attributable to antiretroviral drug treatment, reducing the price of those drugs…
Sep 27 | Beth Jones Sanborn
John Gaffney admitted to taking thousands in cash, signing fake prescriptions for pricey compound medications, the…
Novelion subsidiary to pay $35M over risky cholesterol drug
Sep 26 | Beth Jones Sanborn
Aegerion failed to inform providers of drug's risks outside prescribed usage,…
healthcare fraud
Sep 22 | Beth Jones Sanborn
Roberto A. Fernandez ran a seven-year scheme, took kickbacks, sold prescriptions for addictive opioids…
Anthem acquires MA network HealthSun
Sep 21 | Susan Morse
Acquisition helps position Anthem as a dominant player in a market projected to increase in enrollment, revenue, but…
Biosimilar policy revisions could save $11.4B
Sep 21 | Jeff Lagasse
The Biosimilars Council has urged CMS to revisit their payment and coding policy and provide unique…
Doctors, patients put cost blame on payers, pharma
Sep 19 | Jeff Lagasse
Most say payers should increase prices for those with poor health habits and offer affordable catastrophic…
Pharmacist convicted in $30M compound medication fraud
Sep 19 | Beth Jones Sanborn
Proceeds used to buy a $3.6 million mansion formerly owned by Dwayne "the Rock" Johnson, a…
Sep 18 | Jeff Lagasse
Despite fewer mandates, pediatric hospitals are bullish on how pay-for-quality can improve the health of their patients…